For the past decade and more, the U.S. has been up against a silent but deadly foe, obesity. According to statistics from the Centers for Disease Control (CDC), 36.5% (one third) of American adults and 17% of children were obese by 2019, and the numbers aren’t reducing any time soon. Further research has suggested that over half of the country’s population will be obese within the next ten years, with one in ten Americans being severely obese.
While there are genetic factors that will increase your chances of being obese, it is often a result of poor lifestyle choices, and it has led to a massive surge in type 2 diabetes cases. Ultimately, the best defense against these two deadly conditions is an active lifestyle coupled with a healthy diet. Fortunately, studies have found that cannabis may be a unique treatment to the obesity pandemic that’s been sweeping the country.
How so? First, you have to understand how obesity has become such a big issue in America.
A common joke among non-Americans and Americans themselves is that American portions are comically large. Most of the time, these aren’t healthy foods, and the unfortunate thing is that they are extremely accessible. Constant consumption of such high fat and sugar diets will literally rewire your brain’s reward system, so that each time you indulge in something sweet your brain gets flooded with ‘feel good’ hormones. Thus you will seek out and ingest more sugar, falling into a rabbit hole of low impulse control and unhealthy eating that will lead to obesity and diabetes.
Enter cannabis. Cannabis works by interacting with the endocannabinoid system (ECS), a peripheral nervous system that regulates functions like sleep and pain that determine the internal balance or homeostasis of the body. It produces a variety of chemicals, or cannabinoids, unique to the cannabis plant, and they interact with this system. THCv, or delta-9 tetrahydrocannabivarin, for instance, is involved with lipid and glucose metabolism, and clinical studies on type 2 diabetes have found that it influences glycemic control. In tests on mice, cannabidiol (CBD) has been found to lower the occurrence and delay the onset of diabetes.
Researchers have also suggested that due to its impact on the fat cells that make up the adipose layer, CBD could be used as a potential treatment for diabetes. Cannabis also produces a range of terpenes, many of which have antioxidative properties that promote lipid and glucose metabolism as well as limit chronic inflammation. Ocimene and alpha-bisabolol are especially potent antioxidants, and they can suppress the production of several different inflammatory substances which can lead to type 2 diabetes and hypertension.
Your first defense against obesity and conditions like diabetes and hypertension should be a healthy diet and lifestyle. Coupled with the therapeutic potential of cannabis, this will go a long way in keeping you fit and healthy.
This information is likely to be music to the ears of cannabis companies like Sugarmade Inc. (OTCQB: SGMD) which are convinced that the full benefits of the cannabis plant could take decades to be fully documented.
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Do you have questions or are you interested in working with CNW420? Ask our Editor
CNW420 is part of the InvestorBrandNetwork.